Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarepta Therapeutics
Sarepta Therapeutics
Behind the Sarepta drug approval was intense FDA bickering
Stat/Pharmalot
Mon, 09/19/16 - 03:21 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
FDA approves Sarepta’s controversial drug for Duchenne muscular dystrophy
Stat
Mon, 09/19/16 - 10:07 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics: Wait, I Thought Turmoil at the FDA Was Good News?
Barron's
Thu, 09/15/16 - 07:16 pm
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Drug Critic Departs FDA, Raising Hope for Approval
TheStreet.com
Wed, 09/14/16 - 09:43 am
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
3 Biotech Stocks With Explosive Upside Potential
Motley Fool
Wed, 08/24/16 - 10:53 am
Acadia
Nuplazid
Radius Health
abaloparatide-SC
Sarepta Therapeutics
eteplirsen
Sarepta: The Competition Is At The Gate
Seeking Alpha
Fri, 08/12/16 - 09:53 am
Sarepta Therapeutics
eteplirsen
Biomarin
Summit Therapeutics
PTC Therapeutics
Duchenne Muscular Dystrophy
Sarepta Stock Slides As FDA Sends Another Bad Signal On DMD
Investors.com
Fri, 07/15/16 - 10:15 am
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
Raxone
Kyndrisa
Santhera
Sarepta's Pathway To Approval
Seeking Alpha
Fri, 06/24/16 - 09:30 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA
Sarepta Therapeutics: And Now We Wait
Barron's
Fri, 06/10/16 - 04:13 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
After recent stock surge, Sarepta looks to raise $38M in offering
Bizjournals.com
Thu, 06/9/16 - 10:03 am
Sarepta Therapeutics
eteplirsen
stock offering
FDA’s Woodcock: ‘No connection’ between new drug access policy, Sarepta drug decision
Bizjournals.com
Fri, 06/3/16 - 09:52 pm
FDA
Sarepta Therapeutics
Janet Woodcock
Duchenne Muscular Dystrophy
eteplirsen
Sarepta sinks as FDA changes drug approval rules
CNBC
Thu, 06/2/16 - 04:08 pm
Sarepta Therapeutics
FDA
drug approvals
eteplirsen
Duchenne Muscular Dystrophy
Why BioMarin’s Bad News is Great for Sarepta
Barron's
Wed, 06/1/16 - 09:43 pm
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
Delayed FDA Decision Sends Sarepta Therapeutics Soaring
Yahoo/Market Realist
Fri, 05/27/16 - 12:47 pm
Sarepta Therapeutics
DMD
FDA
eteplirsen
Is the FDA’s decision to delay Sarepta drug decision good or bad? Nobody really knows
Marketwatch
Wed, 05/25/16 - 09:21 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Surges After U.S. Regulators Delay Ruling on DMD Drug
Bloomberg
Wed, 05/25/16 - 09:29 am
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Senators urge FDA to approve Sarepta drug for Duchenne
Stat
Tue, 05/24/16 - 11:12 am
Senate
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
2 End Of May FDA Decisions To Watch
Seeking Alpha
Mon, 05/23/16 - 07:03 pm
FDA
Sarepta Therapeutics
Titan Pharmaceuticals
Duchenne Muscular Dystrophy
eteplirsen
Probuphine
opioid addiction
2 Hotly Debated Drugs Due For FDA Decisions Next Week
Investors.com
Sat, 05/21/16 - 12:35 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Intercept Pharma
Ocaliva
liver disease
primary biliary cholangitis
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »